327 related articles for article (PubMed ID: 35599331)
1. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
[TBL] [Abstract][Full Text] [Related]
2. TRPV1 sustains microglial metabolic reprogramming in Alzheimer's disease.
Lu J; Zhou W; Dou F; Wang C; Yu Z
EMBO Rep; 2021 Jun; 22(6):e52013. PubMed ID: 33998138
[TBL] [Abstract][Full Text] [Related]
3. TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia.
Wang C; Lu J; Sha X; Qiu Y; Chen H; Yu Z
Exp Mol Med; 2023 Feb; 55(2):347-363. PubMed ID: 36720919
[TBL] [Abstract][Full Text] [Related]
4. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
[TBL] [Abstract][Full Text] [Related]
5. Controlled Activation of TRPV1 Channels on Microglia to Boost Their Autophagy for Clearance of Alpha-Synuclein and Enhance Therapy of Parkinson's Disease.
Yuan J; Liu H; Zhang H; Wang T; Zheng Q; Li Z
Adv Mater; 2022 Mar; 34(11):e2108435. PubMed ID: 35023596
[TBL] [Abstract][Full Text] [Related]
6. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
[TBL] [Abstract][Full Text] [Related]
7. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models.
Verma DK; Seo BA; Ghosh A; Ma SX; Hernandez-Quijada K; Andersen JK; Ko HS; Kim YH
Cells; 2021 Jul; 10(7):. PubMed ID: 34359864
[TBL] [Abstract][Full Text] [Related]
10. α-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease.
Tu HY; Yuan BS; Hou XO; Zhang XJ; Pei CS; Ma YT; Yang YP; Fan Y; Qin ZH; Liu CF; Hu LF
Aging Cell; 2021 Dec; 20(12):e13522. PubMed ID: 34811872
[TBL] [Abstract][Full Text] [Related]
11. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
Stoll AC; Kemp CJ; Patterson JR; Howe JW; Steece-Collier K; Luk KC; Sortwell CE; Benskey MJ
Neurobiol Dis; 2024 Feb; 191():106411. PubMed ID: 38228253
[TBL] [Abstract][Full Text] [Related]
13. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
14. Microglial LRRK2-mediated NFATc1 attenuates α-synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation.
Feng L; Lo H; Hong Z; Zheng J; Yan Y; Ye Z; Chen X; Pan X
Glia; 2023 Sep; 71(9):2266-2284. PubMed ID: 37300531
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.
Thome AD; Standaert DG; Harms AS
PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270
[TBL] [Abstract][Full Text] [Related]
16. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.
Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X
J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101
[TBL] [Abstract][Full Text] [Related]
17. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease.
Qin Y; Qiu J; Wang P; Liu J; Zhao Y; Jiang F; Lou H
Brain Behav Immun; 2021 Jan; 91():324-338. PubMed ID: 33039664
[TBL] [Abstract][Full Text] [Related]
18. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy.
Azimullah S; Jayaraj RL; Meeran MFN; Jalal FY; Adem A; Ojha S; Beiram R
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677744
[TBL] [Abstract][Full Text] [Related]
19. Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model.
Stoll AC; Kemp CJ; Patterson JR; Kubik M; Kuhn N; Benskey M; Duffy MF; Luk K; Sortwell CE
Res Sq; 2023 May; ():. PubMed ID: 37205534
[TBL] [Abstract][Full Text] [Related]
20. CIITA expression is regulated by histone deacetylase enzymes and has a role in α-synuclein pre-formed fibril-induced antigen presentation in murine microglial cell line.
Günaydın C; Çelik ZB; Bilge SS
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):447-455. PubMed ID: 35291899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
